FDA approves Roches Tecentriq in combination with Avastin and chemotherapy for the initial treatment of people with a specific type of metastatic lung cancer
Roche announced that the US FDA approved Tecentriq in combination with Avastin, paclitaxel and carboplatin (chemotherapy), for the initial (first-line) treatment of people with...
Shire Receives European Approval for TAKHZYRO (lanadelumab) subcutaneous injection for the Preventive Treatment of Hereditary Angioedema
Shire plc the leading global biotechnology company focused on rare diseases, announced that the European Commission (EC) has granted Marketing Authorisation for TAKHZYRO™ (lanadelumab)...
European Commission Approves Mercks DELSTRIGO
Merck, known as MSD outside the United States and Canada, announced that the EC has approved DELSTRIGO™ and PIFELTRO™ for the treatment of HIV-1...
Sandoz receives eighth European Commission approval for a biosimilar with Ziextenzo
Sandoz, a Novartis division and the pioneer and global leader in biosimilars, announced that the European Commission (EC) granted marketing authorization for biosimilar Ziextenzo®...
FDA Approves First Drug Using the Recombinant Factor C Assay for Endotoxin Testing
Lonza announced that the recombinant Factor C Assay has been used for endotoxin testing of Eli Lilly’s Emgality™ , the first drug approved by...
European Commission has granted Marketing Authorization for Vertex’s SYMKEVI
Vertex Pharmaceuticals Limited, announced that the European Commission has granted Marketing Authorization for SYMKEVI in a combination regimen with ivacaftor for the treatment of...
Roche announces FDA approval of Xofluza (baloxavir marboxil) for influenza
Roche announced that the US FDA has approved Xofluza™ (baloxavir marboxil) for the treatment of acute, uncomplicated influenza, or flu, in people 12 years...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...